This is a StreetInsider.com Premium Only Page

MannKind (MNKD) –

Apr 22, 2024 07:00 PM Form 3 MANNKIND CORP For: Apr 22 Filed by: Prentiss Christopher B

Apr 5, 2024 06:09 AM Form ARS MANNKIND CORP For: Dec 13

Apr 5, 2024 06:09 AM Form DEFA14A MANNKIND CORP

Apr 5, 2024 06:07 AM Form DEF 14A MANNKIND CORP For: May 15

Apr 3, 2024 04:56 PM Form 8-K MANNKIND CORP For: Apr 01

Apr 3, 2024 06:00 AM MannKind (MNKD) Repays Certain Debts

Apr 3, 2024 06:00 AM MannKind Repays Certain Debt Obligations

Mar 29, 2024 09:00 PM Form 4 MANNKIND CORP For: Mar 27 Filed by: Sabella Lauren M

Mar 26, 2024 04:12 PM Form 8-K MANNKIND CORP For: Mar 25

Mar 26, 2024 04:05 PM MannKind (MNKD) Announces CFO Transition

Mar 26, 2024 04:05 PM MannKind Announces CFO Transition

Mar 11, 2024 06:27 AM MannKind (MNKD) announces initial meal challenge data from INHALE-3

Mar 11, 2024 06:05 AM INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps

Mar 5, 2024 06:09 AM MannKind (MNKD) Reports New Clinical Data From Inhale-3 Study

Mar 5, 2024 06:05 AM MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8

Mar 4, 2024 01:01 PM MannKind Corporation Announces Participation at Upcoming Conferences

Feb 28, 2024 08:24 AM MannKind (MNKD) PT Raised to $6.50 at Oppenheimer

Feb 27, 2024 05:25 PM Form 10-K MANNKIND CORP For: Dec 31

Feb 27, 2024 04:05 PM Form 8-K MANNKIND CORP For: Feb 27

Feb 27, 2024 04:04 PM MannKind (MNKD) Tops Q4 EPS by 2c

Feb 27, 2024 04:00 PM MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update

Feb 20, 2024 06:00 AM MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024

Feb 15, 2024 06:07 AM MannKind (MNKD) Completes Enrollment of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza

Feb 15, 2024 06:05 AM MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®

Feb 13, 2024 05:14 PM Form SC 13G/A MANNKIND CORP Filed by: VANGUARD GROUP INC

Feb 5, 2024 06:03 AM Form 4 MANNKIND CORP For: Jun 30 Filed by: Castagna Michael

Feb 5, 2024 06:03 AM Form 4 MANNKIND CORP For: Dec 31 Filed by: BLANK BURKHARD

Feb 5, 2024 06:03 AM Form 4 MANNKIND CORP For: Dec 31 Filed by: Sabella Lauren M

Feb 5, 2024 06:02 AM Form 4 MANNKIND CORP For: Feb 04 Filed by: Kay Sabrina

Feb 5, 2024 06:02 AM Form 4 MANNKIND CORP For: Feb 04 Filed by: HOOPER ANTHONY C

Feb 5, 2024 06:02 AM Form 4 MANNKIND CORP For: Feb 04 Filed by: CONSIGLIO RONALD J

Feb 5, 2024 06:02 AM Form 4 MANNKIND CORP For: Jun 30 Filed by: Tross Stuart A

Jan 25, 2024 05:03 PM Form SC 13G/A MANNKIND CORP Filed by: BlackRock Inc.

Jan 22, 2024 12:57 PM Form SC 13G/A MANNKIND CORP Filed by: STATE STREET CORP

Jan 2, 2024 06:07 AM Form 8-K MANNKIND CORP For: Dec 27

Jan 2, 2024 06:05 AM MannKind (MNKD) Enters $200M Royalty Purchase Agreement with Sagard Healthcare

Jan 2, 2024 06:05 AM MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million

Dec 28, 2023 06:00 AM MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

Dec 27, 2023 04:16 PM Form 8-K MANNKIND CORP For: Dec 22

Dec 15, 2023 09:01 PM Form 4 MANNKIND CORP For: Dec 14 Filed by: Castagna Michael

Dec 15, 2023 04:09 PM Form 144 MANNKIND CORP Filed by: Castagna Michael

Dec 14, 2023 07:57 PM Form 144 MANNKIND CORP Filed by: Castagna Michael

Dec 14, 2023 04:09 PM Form 144 MANNKIND CORP Filed by: Castagna Michael

Nov 7, 2023 04:13 PM Form 10-Q MANNKIND CORP For: Sep 30

Nov 7, 2023 04:06 PM Form 8-K MANNKIND CORP For: Nov 07

Nov 7, 2023 04:02 PM MannKind (MNKD) Tops Q3 EPS by 4c

Nov 7, 2023 04:00 PM MannKind Corporation Reports 2023 Third Quarter Financial Results

Nov 6, 2023 06:16 AM MannKind (MNKD) fully enrolled patients in INHALE-3 Phase 4 trial

Nov 6, 2023 06:15 AM MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes

Nov 2, 2023 09:00 PM Form 4 MANNKIND CORP For: Oct 31 Filed by: Singh Sanjay R